Document is current
Any future updates will be listed below
-
Authors
Kroon, L. J. https://orcid.org/0009-0003-6801-3633
Leeuwenburgh, K. P. https://orcid.org/0000-0003-3024-4789
Remmers, S. https://orcid.org/0000-0001-9530-6448
Kweldam, C. F. https://orcid.org/0000-0002-1581-9612
van den Bergh, R. C. N. https://orcid.org/0000-0002-2605-2453
Bangma, C. H. https://orcid.org/0000-0002-7787-1969
van Leenders, G. J. L. H. https://orcid.org/0000-0003-2176-9102
,
-
Funding
Funding for this research was provided by:
Jaap Schouten Foundation
- License Information
-
More Information
Article History
Received: 19 December 2024
Revised: 9 April 2025
Accepted: 24 April 2025
First Online: 6 June 2025
Declarations
:
: LJK reports that the Jaap Schouten Foundation provided a grant to financially support the PhD work of LJK. The Jaap Schouten Foundation was not involved in the study contents of any kind and also does not have a conflict of interest regarding study contents or results. RCNB reports the following: advisory board (Astellas, Janssen), speaker (Amgen, Astellas, Ipsen, Janssen, MSD), travel grants (Astellas, Bayer), research support (Astellas, Janssen). The other authors have no funding or conflicts of interest to declare.
